MEDINDIA

Search Medindia

Diabetes News

Medindia's Press Release’ section provides the latest press release on Diabetes from across the world for the global audience. This page links to 1474 Diabetes press releases.

Rapid Nexus Unveils First-Ever Medical Technology to Regrow Nerves and Stop Amputations in Diabetic Patients

PR Newswire BREA, Calif., Sept. 23, 2025 This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who ...

Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes

PR Newswire SAN FRANCISCO and SUZHOU, China, Sept. 19, 2025 SAN FRANCISCO and SUZHOU, China, Sept. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...

Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes

PR Newswire INDIANAPOLIS, Sept. 17, 2025 In SURPASS-PEDS, Mounjaro met the primary and all key secondary endpoints at 30 weeks and showed sustained improvement in glycemic control and continued BMI reduction through the study's 52-week ...

Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting

PR Newswire HONG KONG, Sept. 16, 2025 -          ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment. -          ASC30 tablet's higher efficacy is ...

NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients

PR Newswire ZURICH, Sept. 4, 2025 ZURICH, Sept. 4, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS" or the "Company") today announced that its merger partner Kadimastem Ltd. (TASE: KDST) ("Kadimastem") has been granted a ...

New Peer-Reviewed Study in New England Journal of Medicine Catalyst Finds Twin Health's AI Precision Treatment Significantly Improves Outcomes in Patients with Type 2 Diabetes and Reduces Reliance on Costly Medications, Including GLP-1s

PR Newswire MOUNTAIN VIEW, Calif., Aug. 20, 2025 Cleveland Clinic-led study finds Twin Health's precision AI and hyper-personalized care outperforms standard diabetes treatment—reducing A1C, unhealthy weight, and medication use MOUNTAIN ...

Latest Breakthrough in Type 1 Diabetes Treatment: Chinese Medical Team Enables 24 Patients to Discontinue Insulin Use

SHENZHEN, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients ...

Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines

PR Newswire PLAINSBORO, N.J., Aug. 18, 2025 PLAINSBORO, N.J., Aug. 18, 2025 /PRNewswire/ -- Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type 2 diabetes patients access to authentic, FDA-approved ...

ViCentra to Bring Smartphone-Based Closed Loop Therapy to People with Diabetes in Early 2026

PR Newswire UTRECHT, the Netherlands, Aug. 12, 2025 Kaleido patch pump system with Diabeloop's DBLG2 algorithm and Dexcom G7 CGM to launch in Germany and the Netherlands in early 2026, bringing smartphone-controlled closed loop therapy to ...

Breakthrough T1D, formerly JDRF, Leads Multi-Stakeholder Summit in Udaipur, India Highlighting Urgent Need for Early Diagnosis, Access to Care, and Stigma Reduction for Type 1 Diabetes

PR Newswire NEW YORK, Aug. 5, 2025 NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Breakthrough T1D International, the leading global type 1 diabetes (T1D) research and advocacy organization, in partnership with Friends of Mewar and UNICEF concluded ...

Diabetes News »

Are Your Teeth Paying the Hidden Cost of High Blood Sugar?

Are Your Teeth Paying the Hidden Cost of High Blood Sugar?

Presence of high blood sugar in diabetic patients boosts cavity causing bacteria in saliva and significantly increases the risk of dental cavities.

Catching the Immune System Betrayal to Decode the Diabetes

Catching the Immune System Betrayal to Decode the Diabetes

A distinct type of immune cells was found in pancreas of type 1 diabetic people; the discovery offers target for early detection and prevention of diabetes.

WHO Unveils First Global Diabetes-in-Pregnancy Guide

WHO Unveils First Global Diabetes-in-Pregnancy Guide

WHO releases its first global guidelines for diabetes in pregnancy, aiming to prevent life-threatening complications and improve outcomes for millions of mothers and babies.

From Deadlines to Diabetes: Managing Stress at Work

From Deadlines to Diabetes: Managing Stress at Work

Workplace stress, long hours, and unhealthy habits are raising diabetes risk among India’s young professionals. Awareness and lifestyle changes are key.

 A Shot of Hope: Diabetes Meds May Cut Colon Cancer Death Risk by Half

A Shot of Hope: Diabetes Meds May Cut Colon Cancer Death Risk by Half

Researchers found patients on GLP-1 drugs were less than half as likely to die within five years, hinting at a powerful new link between metabolic health and cancer survival.

More Diabetes News

⬆️